Autres langues Guizhou Yibai Pharmaceutical Co., Ltd.

Actions

600594

CNE000001H03

Produits pharmaceutiques

Cours en clôture Shanghai S.E. 10/09/2026			Varia. 5j.	Varia. 1 janv.
3,700 ^CNY	-3,39 %		-6,80 %	-7,04 %

20/08	Guizhou Yibai Pharmaceutical Co., Ltd. publie ses résultats pour le premier semestre clos le 30 juin 2026	CI
22/04	Guizhou Yibai Pharmaceutical Co., Ltd. publie ses résultats pour le premier trimestre clos le 31 mars 2026	CI

Autres langues

20/08	Guizhou Yibai Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2026
22/04	Guizhou Yibai Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2026
29/10/25	Guizhou Yibai Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2025
18/09/25	Authorities Lift Suspension Order on Yibai Pharma's Production, Sales of Children's Cough Syrup
20/08/25	Guizhou Yibai Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2025
06/08/25	Yibai Pharmaceutical Gets Order to Suspend Marketing of Children's Cough Syrup
25/04/25	Guizhou Yibai Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2025
28/11/24	Guizhou Yibai Pharmaceutical Co., Ltd. 's Equity Buyback announced on November 29, 2023 has expired.
25/10/24	Guizhou Yibai Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2024
10/10/24	Tranche Update on Guizhou Yibai Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on November 30, 2023.
09/09/24	Guizhou Yibai Pharmaceutical CFO Steps Down; Successor Named
04/09/24	Guizhou Yibai Pharmaceutical Gets China Approval for Multiple, Non-Hodgkin's Lymphoma Drug
23/08/24	Guizhou Yibai Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2024
03/07/24	Tranche Update on Guizhou Yibai Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on November 30, 2023.
18/04/24	Guizhou Yibai Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024
30/11/23	YiBai Pharma to Repurchase Up to 40 Million Yuan Shares
30/11/23	Guizhou Yibai Pharmaceutical Co., Ltd. announces an Equity Buyback for CNY 40 million worth of its shares.
29/11/23	Guizhou Yibai Pharmaceutical Co., Ltd. authorizes a Buyback Plan.
26/10/23	Guizhou Yibai Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023
17/08/23	Guizhou Yibai Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023
27/04/23	Guizhou Yibai Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023
27/04/23	Guizhou Yibai Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022
25/01/23	GuiZhou YiBai Pharma to Book 2022 Loss on Policy Changes, COVID-19
24/11/22	Guizhou Yibai Pharmaceutical Completes Construction of $84.5 Million Factory
27/10/22	Guizhou Yibai Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022